Scots Scientists Make MS Treatment Breakthrough that Could Halt Disability Progression
Scientists in Scotland have achieved a significant breakthrough in the treatment of multiple sclerosis (MS), potentially offering hope for halting the disease’s progression. Researchers at Edinburgh University have developed a new method for repairing myelin, which could stop disability advancement in MS patients. Myelin, the protective coating around nerves, is damaged in MS, impeding the transmission of messages from the brain. This damage can impact various functions such as movement, vision, cognition, and sensation.
The body has a natural ability to repair myelin, preserving nerve function. However, this repair process is less effective in MS. With approximately 17,000 Scots living with MS, one of the highest rates globally, the research holds promise for improving outcomes for those affected by the disease. The MS Society Edinburgh Centre for MS Research conducted tests on genetically engineered human cells in mice, demonstrating the cells’ ability to repair damaged myelin.
Joanne Newall, a 36-year-old from Kilmarnock diagnosed with relapsing-remitting MS in 2021, expressed optimism about the research progress. As the Group Coordinator of the MS Society Ayrshire and Arran Local Group, Joanne highlighted the importance of ongoing research efforts in Scotland to combat disability progression in MS patients. She mentioned being encouraged by the potential of moving towards human trials, offering hope for a future without MS.
Professor Anna Williams, leading the study on regenerative neurology, explained the innovative approach taken by the research team. By genetically modifying human oligodendrocyte progenitor cells to ignore inhibitory signals, the scientists observed improved myelin repair in mouse models. Dr. Laura Wagstaff, a postdoctoral researcher at the university, emphasised that the study represents a proof of concept, paving the way for potentially editing cells directly in humans to promote myelin repair without the need for transplants.
Caitlin Astbury, the Research Communications Manager at the MS Society, noted the significance of finding methods to repair myelin damage beyond the current immune system-targeted treatments for MS. The society funded the study, underscoring its value in advancing understanding of myelin repair mechanisms. For more information on supporting essential MS research, visit www.mssociety.org.uk/stop-ms.